Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

LENSAR Inc

Healthcare US LNSR

5.6USD
-0.02(0.36%)

Last update at 2026-06-05T20:00:00Z

Day Range

5.505.73
LowHigh

52 Week Range

1.805.30
LowHigh

Fundamentals

  • Previous Close 5.62
  • Market Cap51.29M
  • Volume47377
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-8.50400M
  • Revenue TTM44.50M
  • Revenue Per Share TTM4.00
  • Gross Profit TTM 19.95M
  • Diluted EPS TTM-1.18

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -19.91400M -19.60100M -19.77400M -14.65700M -
Minority interest - - - - -
Net income -19.65100M -19.65200M -21.18200M -16.71600M -
Selling general administrative 27.17M 23.89M 23.77M 17.15M -
Selling and marketing expenses - - - - -
Gross profit 19.95M 17.83M 14.07M 13.23M -
Reconciled depreciation 3.41M 2.76M 2.56M 3.87M -
Ebit -20.17700M -19.65200M -18.50200M -12.71400M -9.31600M
Ebitda -19.02900M -18.36100M -17.17800M -8.79000M -
Depreciation and amortization 1.15M 1.29M 1.32M 3.92M -
Non operating income net other - - - - -
Operating income -20.17700M -19.65200M -18.50200M -12.71400M -
Other operating expenses 55.53M 54.11M 44.88M 43.24M -
Interest expense 0.26M 1.19M 1.34M 2.00M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - 0.00000M -1.34000M -2.00100M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.26300M 0.05M 1.41M 2.06M 0.02M
Total revenue 35.36M 34.46M 26.38M 30.53M -
Total operating expenses 40.13M 37.48M 32.58M 25.94M -
Cost of revenue 15.40M 16.63M 12.31M 17.30M -
Total other income expense net 0.26M 0.05M -1.27200M -1.94300M -
Discontinued operations - - - - -
Net income from continuing ops -19.91400M -19.60100M -19.77400M -14.65700M -
Net income applicable to common shares -19.91400M -19.60100M -19.77400M -14.65700M -14.04400M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 69.58M 55.84M 66.47M 79.12M 34.54M
Intangible assets 11.03M 12.12M 10.87M 12.11M 13.37M
Earning assets - - - - -
Other current assets 2.37M 1.06M 1.70M 1.86M 0.62M
Total liab 22.41M 13.86M 11.59M 11.91M 65.09M
Total stockholder equity 47.18M 41.98M 54.88M 67.21M -30.55300M
Deferred long term liab - - - - -
Other current liab 5.72M 4.70M 4.60M 0.49M 0.70M
Common stock 0.11M 0.11M 0.11M 0.11M 0.01M
Capital stock 0.11M 0.11M 0.11M 0.11M 0.01M
Retained earnings -111.89100M -97.50800M -77.59400M -57.99300M -38.18500M
Other liab - 0.17M 0.07M 0.13M 0.31M
Good will - - - - -
Other assets 0.00000M 0.50M 3.34M 7.79M 0.98M
Cash 20.62M 14.67M 31.64M 40.60M 4.62M
Cash and equivalents - - - - -
Total current liabilities 11.63M 11.42M 8.71M 8.47M 7.83M
Current deferred revenue 1.35M 0.77M 0.90M 0.92M 0.78M
Net debt -18.31200M -11.87100M -28.83400M -37.28500M 15.92M
Short term debt 0.56M 0.53M 0.51M 4.57M 4.78M
Short long term debt - - - - -
Short long term debt total 2.31M 2.80M 2.80M 3.31M 20.53M
Other stockholder equity 145.20M 139.38M 132.36M 125.09M 7.62M
Property plant equipment - 9.51M 7.45M 8.08M 3.00M
Total current assets 46.44M 33.72M 44.81M 58.38M 17.18M
Long term investments 0.49M - - - -
Net tangible assets - 29.86M 44.01M 55.10M -43.91900M
Short term investments 3.44M - - - -
Net receivables 4.32M 6.24M 4.99M 2.46M 3.89M
Long term debt - - - - 20.20M
Inventory 15.69M 11.74M 6.49M 13.47M 8.06M
Accounts payable 4.01M 5.42M 2.69M 2.48M 1.58M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00400M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - 0.11M 0.01M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.07M 3.13M 3.34M 4.21M 1.84M
Deferred long term asset charges - - - - -
Non current assets total 23.14M 22.13M 21.65M 20.73M 17.35M
Capital lease obligations 2.31M 2.80M 3.31M 3.31M 0.33M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.11500M -0.35400M -0.32600M -2.08900M -
Change to liabilities 2.73M 0.21M 0.91M 0.13M 0.66M
Total cashflows from investing activities -0.11500M -0.35400M -0.32600M -2.08900M -3.89200M
Net borrowings - - 12.40M 13.22M 3.50M
Total cash from financing activities -1.99200M 0.36M 50.00M 15.95M 6.96M
Change to operating activities 0.02M 0.07M 0.27M 2.27M 5.69M
Net income -19.91400M -19.60100M -19.77400M -14.65700M -12.59300M
Change in cash -16.96300M -8.96200M 35.88M 1.27M 1.18M
Begin period cash flow 31.64M 40.60M 4.71M 3.44M -
End period cash flow 14.67M 31.64M 40.60M 4.71M 3.44M
Total cash from operating activities -14.85600M -8.96900M -13.79100M -12.58900M -1.88500M
Issuance of capital stock - 0.00000M 39.46M 3.83M -
Depreciation 3.41M 2.76M 2.56M 3.87M 4.59M
Other cashflows from investing activities - - - - -
Dividends paid - 0.00000M 1.86M 0.03M 0.20M
Change to inventory -6.88900M 2.33M -8.69700M -4.77300M -0.87600M
Change to account receivables -1.44000M -2.65400M 1.33M 0.01M 0.44M
Sale purchase of stock 0.41M 0.36M - - -
Other cashflows from financing activities -2.40000M -0.35400M 12.40M 12.15M -0.21400M
Change to netincome 7.23M 7.91M 9.61M 0.56M 0.20M
Capital expenditures 0.12M 0.35M 0.37M 2.09M 1.16M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -5.57700M -0.04200M -6.18900M -2.35900M -
Stock based compensation 6.61M 6.87M 9.04M 0.10M -
Other non cash items 0.62M 0.52M 0.51M 0.54M -
Free cash flow -14.97100M -9.32300M -14.15700M -14.67800M -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LNSR
LENSAR Inc		 -0.02 0.36% 5.60 - - 0.89 1.12 0.37 -1.7927
ABT
Abbott Laboratories		 0.29 0.32% 91.07 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 4.45 1.48% 305.66 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -0.26 0.32% 81.67 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.3 0.61% 48.55 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

LENSAR Inc

2800 Discovery Drive, Orlando, FL, United States, 32826

Key Executives

Name Title Year Born
Mr. Nicholas T. Curtis CEO & Director 1956
Mr. Thomas R. Staab II, CPA CFO & Sec. 1968
Mr. Alan B. Connaughton Chief Operating Officer 1972
Ms. Kendra W. Wong Principal Accounting Officer 1980
Mr. Nicholas T. Curtis President, CEO & Director 1957
Mr. Thomas R. Staab II, CPA CFO & Secretary 1968

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions